Export-oriented API manufacturing facility spread over 22.4 acres with 10 blocks and 175,000L total reactor capacity for global pharmaceutical markets
Shilpa Pharma Life Sciences - Unit II is our premier 100% Export Oriented API manufacturing facility, strategically designed to serve global pharmaceutical markets with world-class quality standards and exceptional production capabilities.
This state-of-the-art facility is dedicated exclusively to manufacturing APIs for international markets, ensuring compliance with the most stringent global regulatory standards and serving pharmaceutical companies worldwide.
Spread over 22.4 acres (906,304 sq.m) with world-class manufacturing blocks and support facilities
State-of-the-art blocks comprising 5 dedicated Oncology and 5 Non-Oncology production units
Total reactor capacity of 175,000L (53,000L Non-Oncology + 122,000L Oncology) for large-scale manufacturing
ISO 14001:2004 certified with approvals from 7 major international regulatory authorities
Unit II houses cutting-edge technologies and specialized expertise in advanced pharmaceutical chemistry, making it a preferred partner for complex API manufacturing:
Advanced separation techniques including crystallization, chromatography, and specialized purification methods for high-purity APIs
Expertise in stereoselective reactions and asymmetric catalysis for producing optically pure pharmaceutical compounds
State-of-the-art chiral resolution and synthesis capabilities for single enantiomer production with high optical purity
Specialized expertise in catalytic hydrogenation, chemical reductions, and selective reduction processes under various conditions
Flexible CRAMS capabilities for custom synthesis projects from route development to commercial-scale manufacturing
Comprehensive contract research and manufacturing services tailored to global pharmaceutical company requirements
Unit II holds certifications and approvals from the world's most stringent regulatory authorities, ensuring our APIs meet international quality standards for export to global markets:
As a 100% Export Oriented Unit, this facility is specifically designed and authorized to manufacture APIs exclusively for international markets, providing significant advantages:
Unit II is strategically located adjacent to the Hyderabad-Raichur National Highway, providing excellent connectivity for efficient logistics and export operations:
